Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nedderman DM"'
Autor:
Holzer TR; Diagnostic and Experimental Pathology, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A. holzertr@lilly.com nasirae@lilly.com., Fulford AD; Diagnostic and Experimental Pathology, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A., Reising LO; Diagnostic and Experimental Pathology, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A., Nedderman DM; Diagnostic and Experimental Pathology, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A., Zhang X; Oncology Statistics, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A., Benjamin LE; Cancer Biology and Angiogenesis, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A., Schade AE; Diagnostic and Experimental Pathology, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A., Nasir A; Diagnostic and Experimental Pathology, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A. holzertr@lilly.com nasirae@lilly.com.
Publikováno v:
Anticancer research [Anticancer Res] 2016 Jul; Vol. 36 (7), pp. 3277-88.
Autor:
Nasir A; Diagnostic and Experimental Pathology, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A. nasirae@lilly.com., Reising LO; Diagnostic and Experimental Pathology, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A., Nedderman DM; Diagnostic and Experimental Pathology, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A., Fulford AD; Diagnostic and Experimental Pathology, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A., Uhlik MT; Cancer Biology and Angiogenesis, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A., Benjamin LE; Cancer Biology and Angiogenesis, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A., Schade AE; Diagnostic and Experimental Pathology, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A., Holzer TR; Diagnostic and Experimental Pathology, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, U.S.A.
Publikováno v:
Anticancer research [Anticancer Res] 2016 Jun; Vol. 36 (6), pp. 2683-96.
Autor:
Holzer TR; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America., Fulford AD, Nedderman DM, Umberger TS, Hozak RR, Joshi A, Melemed SA, Benjamin LE, Plowman GD, Schade AE, Ackermann BL, Konrad RJ, Nasir A
Publikováno v:
PloS one [PLoS One] 2013 Nov 14; Vol. 8 (11), pp. e80292. Date of Electronic Publication: 2013 Nov 14 (Print Publication: 2013).